MedTrace Logo

24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD Patients

NCT04543721 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-09-10

No results posted yet for this study

Summary

Evaluation of the individual cardiovascular risk profile of patients with non-alcoholic fatty liver disease (NAFLD) using 24-hour ambulatory long-term blood pressure measurement and pulse wave analysis

Conditions

  • NAFLD; Hypertension, White-coat Hypertension, Masked Hypertension

Interventions

DEVICE

24-h-ABPM

24-h- blood pressure measurement and pulse wave analysis

Sponsors & Collaborators

  • University Hospital of Cologne

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04543721 on ClinicalTrials.gov